| Style | Citing Format |
|---|---|
| MLA | Seirafianpour F, et al.. "Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?." Dermatologic Therapy, vol. 33, no. 4, 2020, pp. -. |
| APA | Seirafianpour F, Mozafarpoor S, Fattahi N, Sadeghzadehbazargan A, Hanifiha M, Goodarzi A (2020). Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?. Dermatologic Therapy, 33(4), -. |
| Chicago | Seirafianpour F, Mozafarpoor S, Fattahi N, Sadeghzadehbazargan A, Hanifiha M, Goodarzi A. "Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?." Dermatologic Therapy 33, no. 4 (2020): -. |
| Harvard | Seirafianpour F et al. (2020) 'Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?', Dermatologic Therapy, 33(4), pp. -. |
| Vancouver | Seirafianpour F, Mozafarpoor S, Fattahi N, Sadeghzadehbazargan A, Hanifiha M, Goodarzi A. Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?. Dermatologic Therapy. 2020;33(4):-. |
| BibTex | @article{ author = {Seirafianpour F and Mozafarpoor S and Fattahi N and Sadeghzadehbazargan A and Hanifiha M and Goodarzi A}, title = {Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?}, journal = {Dermatologic Therapy}, volume = {33}, number = {4}, pages = {-}, year = {2020} } |
| RIS | TY - JOUR AU - Seirafianpour F AU - Mozafarpoor S AU - Fattahi N AU - Sadeghzadehbazargan A AU - Hanifiha M AU - Goodarzi A TI - Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy? JO - Dermatologic Therapy VL - 33 IS - 4 SP - EP - PY - 2020 ER - |